Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape
Eisai (United States) · Eisai (Japan) · +16 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
238
total citations
- FWCI
- 47.70
- Percentile
- 100%
- References
- 167
Citations per year
Authors
15Topics & keywords
Topics
Keywords
- Disease
- State (computer science)
- Neuroscience
- Health care
- Alzheimer's disease
- Current (fluid)
- Medicine
- Biology
No related works found for this paper.
Funding
- ADAlzheimer's Drug Discovery FoundationAward: P20GM109025
- ELEli Lilly and CompanyAward: P20GM109025
- BBiogenAward: P20GM109025
- UOUniversity of Pennsylvania
- CACure Alzheimer's Fund
- JAJapan Agency for Medical Research and DevelopmentAwards: JP22ae0101077, JP20dk0207027, JP22dk0207052
- STSage Therapeutics
- PProthena
- EEisaiAward: P20GM109025
- NNNovo Nordisk
- NCNational Center for Geriatrics and Gerontology
- SHSiemens Healthineers
- SServierAward: P20GM109025
- HLH. Lundbeck A/SAward: P20GM109025
- GGrifols
- JCJulius Clinical
- NINational Institutes of HealthAwards: P30AG072959, R01AG070941, U19AG078109, ADNI4, U19AG024904, R01AG058533, U01NS093334, P20GM109025
- GGenentechAward: P20GM109025
- NINational Institute on AgingAwards: P20GM109025, P30AG072959, U19AG078109, P30-AG-072979, U19AG024904, R35AG71476, P20AG068053, R01AG053798, R01AG070941, R01AG058533
- NINational Institute of General Medical SciencesAwards: P20AG068053, P20GM109025
- NINational Institute of Neurological Disorders and StrokeAward: U01NS093334